Ubc9 promotes breast cell invasion and metastasis in a sumoylation-independent manner. - Wikidata - awgldk - TriplyDB

Ubc9 promotes breast cell invasion and metastasis in a sumoylation-independent manner.

Ubc9 promotes breast cell invasion and metastasis in a sumoylation-independent manner.

http://www.wikidata.org/entity/Q33753966

about

SUMOylation-Mediated Regulation of Cell Cycle Progression and Cancer MicroRNAs in breast cancer: oncogene and tumor suppressors with clinical potential Decreased levels of miR-224 and the passenger strand of miR-221 increase MBD2, suppressing maspin and promoting colorectal tumor growth and metastasis in mice SUMO Ubc9 enzyme as a viral target microRNA-224 regulates Pentraxin 3, a component of the humoral arm of innate immunity, in inner ear inflammation microRNA-214-mediated UBC9 expression in glioma.Elevated global SUMOylation in Ubc9 transgenic mice protects their brains against focal cerebral ischemic damage.Ubiquitin-conjugating enzyme 9 promotes epithelial ovarian cancer cell proliferation in vitro.Decreased microRNA-224 and its clinical significance in non-small cell lung cancer patients Human Ubc9 is involved in intracellular HIV-1 Env stability after trafficking out of the trans-Golgi network in a Gag dependent manner.Coactivation of SF-1-mediated transcription of steroidogenic enzymes by Ubc9 and PIAS1 Estrogen receptor alpha and nuclear factor Y coordinately regulate the transcription of the SUMO-conjugating UBC9 gene in MCF-7 breast cancer cells.SUMOylation is required for optimal TRAF3 signaling capacity microRNAs' differential regulations mediate the progress of Human Papillomavirus (HPV)-induced Cervical Intraepithelial Neoplasia (CIN).MicroRNA-mediated drug resistance in breast cancer.Oncogenesis driven by the Ras/Raf pathway requires the SUMO E2 ligase Ubc9.Roles of ubiquitination and SUMOylation on prostate cancer: mechanisms and clinical implications.The SUMO conjugating enzyme UBC9 as a biomarker for cervical HPV infections.Ubc9 mediates nuclear localization and growth suppression of BRCA1 and BRCA1a proteins Salmonella Engages Host MicroRNAs To Modulate SUMOylation: a New Arsenal for Intracellular Survival.BRCA1 proteins regulate growth of ovarian cancer cells by tethering Ubc9 Autophagy regulates UBC9 levels during viral-mediated tumorigenesis.Uncoupling phototoxicity-elicited neural dysmorphology and death by insidious function and selective impairment of Ran-binding protein 2 (Ranbp2).Increased expression of importin13 in endometriosis and endometrial carcinoma.Small ubiquitin-like modifier 1-3 conjugation [corrected] is activated in human astrocytic brain tumors and is required for glioblastoma cell survival.Long-Term Memory in Drosophila Is Influenced by Histone Deacetylase HDAC4 Interacting with SUMO-Conjugating Enzyme Ubc9.Role of SUMO activating enzyme in cancer stem cell maintenance and self-renewal.Polymorphism of UBC9 gene encoding the SUMO-E2-conjugating enzyme and breast cancer risk.MicroRNA-224 inhibits proliferation and migration of breast cancer cells by down-regulating Fizzled 5 expression.MicroRNA-224 suppresses colorectal cancer cell migration by targeting Cdc42.Human pathogens and the host cell SUMOylation system.Pleiotropic function of SRY-related HMG box transcription factor 4 in regulation of tumorigenesis.Regulation of breast cancer tumorigenesis and metastasis by miRNAs.SUMO rules: regulatory concepts and their implication in neurologic functions.Methionine adenosyltransferase α2 sumoylation positively regulate Bcl-2 expression in human colon and liver cancer cells.CXCL12/CXCR4: a symbiotic bridge linking cancer cells and their stromal neighbors in oncogenic communication networks.SUMO pathway components as possible cancer biomarkers.MicroRNA-224: as a potential target for miR-based therapy of cancer.Tumour-suppressive microRNA-224 inhibits cancer cell migration and invasion via targeting oncogenic TPD52 in prostate cancer.Tumor microenvironment and noncoding RNAs as co-drivers of epithelial-mesenchymal transition and cancer metastasis.

P2860

Q26776081-22EA344C-5CBC-41FD-9549-CA0D60D11514 Q28081081-3FCD72D1-E2D6-486B-9C9B-ED8044432B2D Q28118790-213D42AD-E9B7-40F5-A5D3-AA02C5E25004 Q28305355-EC22E00B-BD74-4833-B0E5-B872EBEC6B7C Q33649267-34AA0ACA-6D2C-44B4-9C32-90AE3395959F Q34049130-05B8F772-264B-49BD-B14E-CFAC25DA5A00 Q34053347-BF59CDAF-8F4A-4B31-989A-AB4652F2F811 Q34346747-8001DF8F-CBDD-47F5-A1E0-8175F92DFA59 Q34578852-9A7176CB-6947-4204-949B-0FF40C6750C7 Q34828531-4D85E558-CD6F-4A28-A177-F52B6FFC9D74 Q35001325-B6F638AC-7A09-4B33-A0FB-EB565F4F6A03 Q35005904-98CEC60F-FA28-4BCE-A4A0-C729F69BE818 Q35049033-F4AE2796-BE0D-4659-844A-72910F8082C5 Q35109719-18EC6E4B-0050-4347-928B-80D8CC0CF553 Q35165126-F485119F-7D1F-4DBA-92AD-73333895EC4B Q35378365-1BF352E7-A3D1-4E2D-BB6A-12D1C93E14AD Q35380380-13986E40-D33A-448E-959B-8BDC68C2B878 Q35619352-6B1F63B1-9F93-48A6-8397-AFC935915BB5 Q35898032-03D41CA0-7F18-42F5-ABDB-8FF3D9905A32 Q35917486-E4FE2039-114C-48B1-B488-25A8DDF49728 Q36206491-E1DBFC60-BF97-489B-96A8-A2E019B2A234 Q36295602-3C718057-1FC1-4AE1-8110-9E6DE9893B15 Q36575234-C9257242-E230-4E5F-8434-1AD060132DD3 Q36577388-DA33BCFF-524B-4422-BBBF-282375CF05F6 Q36717273-EA6E37D5-08D6-427F-932E-B3EEA48BC59D Q37076788-AFA31582-FC9B-45D3-91A2-9F6FCB42820A Q37153640-43E308D0-04BA-4608-A684-B8191F4D527B Q37471156-EF027D28-14E6-40CB-9523-45CF15EC8C9B Q37580183-150615B8-6638-410F-8556-BFF414FFB87F Q37731426-09644B66-0762-41B4-A7D2-5C1EE4D1A46D Q37954599-9D3593DF-4B2D-411A-8033-7CB7B948C264 Q38053346-0A7CF90D-B22D-42BA-8EC7-0B265FE0DE2E Q38068926-CD9D906F-0DC7-48A0-B54E-FC7A515CB22F Q38132691-B7AB01F9-9D94-4B5D-B1AE-77D2FA485E5C Q38262063-A85DD181-4268-4C1F-AF17-F53F219CBC82 Q38472331-DA18FB16-9D0F-4F54-AEBA-96D9036C5B85 Q38515816-576C8870-79CA-4A89-928D-EF1589B17340 Q38562796-5826E7D5-0D35-44AB-BB19-64727BE3F995 Q39001066-82B0629C-4DB2-47B4-B7AD-3E0DB722FCB2 Q39425138-3E995A9E-C6C8-40C4-99A0-9E6CA61565BF

P2860

Ubc9 promotes breast cell invasion and metastasis in a sumoylation-independent manner.

http://www.wikidata.org/entity/Q33753966

description

2009 nî lūn-bûn

@nan

2009 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Ubc9 promotes breast cell invasion and metastasis in a sumoylation-independent manner.

@ast

Ubc9 promotes breast cell invasion and metastasis in a sumoylation-independent manner.

@en

type

label

Ubc9 promotes breast cell invasion and metastasis in a sumoylation-independent manner.

@ast

Ubc9 promotes breast cell invasion and metastasis in a sumoylation-independent manner.

@en

prefLabel

Ubc9 promotes breast cell invasion and metastasis in a sumoylation-independent manner.

@ast

Ubc9 promotes breast cell invasion and metastasis in a sumoylation-independent manner.

@en

P1433

Q33753966-795936FF-3624-49FF-9C55-1660E3220C37

P1476

Q33753966-194F5E36-FF6E-4CC6-9310-81EB4B453A33

P2093

Q33753966-45D1AF13-787C-4C3B-B08A-184CA53DD884

Q33753966-9B0790EF-8438-489B-B9D7-B57983539228

Q33753966-B9E10EAA-7089-4A42-8091-5A33335E48B1

Q33753966-F02CE13B-5678-4897-A9B2-0F08B161AA8C

Q33753966-FB113101-3375-464D-9F48-3C7454A11095

P2860

Q33753966-14D726E1-423E-4215-830D-22213A268FBA

Q33753966-160AEFBB-E4B1-4921-8EDB-E26DDB3DD03C

Q33753966-18D870AE-82F3-4A55-BBFE-FC6CD2596F10

Q33753966-1FA99019-E1C6-4098-9CA5-FBB76A3B7F35

Q33753966-2309AA2C-AEDC-4DA2-AB01-89B05CF1E836

Q33753966-29BDDF01-07E0-46E6-A9B4-6D8096FF31A8

Q33753966-2BC56BB0-D7E8-431A-ACAA-D99A613B2F22

Q33753966-32A4BE55-9AFB-420E-903A-DD0F4D5BF55E

Q33753966-385F7A44-3E13-49F6-B76D-0D7FAF565ED5

Q33753966-3B02D499-2881-4862-8500-35879301A37D

P2888

Q33753966-93A26ED0-4111-43D3-ADCA-F6FED738B0D5

P304

Q33753966-D1F51FAD-A248-441C-9D72-D9CEE98CD49A

P31

Q33753966-FC17E962-3736-47F6-B794-7EE62368D2E8

P356

Q33753966-D3035E9B-420B-4BC7-9538-F4072998B391

P407

Q33753966-9276E4FB-6232-4478-8455-E6C83A6E2A38

P433

Q33753966-8387AE22-8F58-470C-81BA-432080CDBCD7

P478

Q33753966-0CD21C18-88D3-4F36-A432-91C70819D2DF

P577

Q33753966-2B5BAF67-DD25-4C31-8084-E68D41C81E93

P5875

Q33753966-09596B60-2659-40BC-A5B6-21E2268F515A

P6179

Q33753966-E1E1FEDE-D826-4A07-BDDC-1073E142F6EC

P698

Q33753966-3847130B-08D1-4E3E-B3DA-36DAA38878F1

P932

Q33753966-EBC7307E-23DE-418F-913E-13A0C7A1FC07

P356

P1433

P1476

Ubc9 promotes breast cell invasion and metastasis in a sumoylation-independent manner.

@en

P2093

F Wu

http://www.w3.org/2001/XMLSchema#string

M Sachdeva

http://www.w3.org/2001/XMLSchema#string

S Zhu

http://www.w3.org/2001/XMLSchema#string

Y-Y Mo

http://www.w3.org/2001/XMLSchema#string

Z Lu

http://www.w3.org/2001/XMLSchema#string

P2860

Real-time quantification of microRNAs by stem-loop RT-PCR

The miR-200 family inhibits epithelial-mesenchymal transition and cancer cell migration by direct targeting of E-cadherin transcriptional repressors ZEB1 and ZEB2

Selective blockade of microRNA processing by Lin28

p53 represses c-Myc through induction of the tumor suppressor miR-145

The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2

A microRNA polycistron as a potential human oncogene

MicroRNA signatures in human cancers

MicroRNAs: genomics, biogenesis, mechanism, and function

Tumour invasion and metastasis initiated by microRNA-10b in breast cancer

Ubc9 is a novel modulator of the induction properties of glucocorticoid receptors

P2888

P304

1763-1772

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/ONC.2009.459

http://www.w3.org/2001/XMLSchema#string

P407

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

29

http://www.w3.org/2001/XMLSchema#string

P577

2009-12-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

40731195

http://www.w3.org/2001/XMLSchema#string

P6179

1039107474

http://www.w3.org/2001/XMLSchema#string

P698

20023705

http://www.w3.org/2001/XMLSchema#string

P932

2845735

http://www.w3.org/2001/XMLSchema#string